Control Material for Quality Assessment of Quantitative Determination of Hepatitis B Surface Antigen (HBsAg) in Clinical Samples Using Chemiluminescent Immunoassay on CL Series Analyzers

Control Material for Quality Assessment of Quantitative Determination of Hepatitis B Surface Antigen (HBsAg) in Clinical Samples Using Chemiluminescent Immunoassay on CL Series Analyzers

This control material is intended for use in quality control procedures for the quantitative detection of hepatitis B surface antigen (HBsAg) using chemiluminescent immunoassay (CLIA) on CL series analyzers.

Available Variants:

• Negative Control Material
  Configuration: 3 x 2.0 mL vials
  Contents: HBsAg Negative Control, 2.0 mL – 3 vials
  Includes: Control value sheet, usage instructions
• Negative Control Material
  Configuration: 6 x 2.0 mL vials
  Contents: HBsAg Negative Control, 2.0 mL – 6 vials
  Includes: Control value sheet, usage instructions
• Positive Control Material
  Configuration: 3 x 2.0 mL vials
  Contents: HBsAg Positive Control, 2.0 mL – 3 vials
  Includes: Control value sheet, usage instructions
• Positive Control Material
  Configuration: 6 x 2.0 mL vials
  Contents: HBsAg Positive Control, 2.0 mL – 6 vials
  Includes: Control value sheet, usage instructions

If your organization wants to sell medical equipment, medical products or medical consumables in Russia, for example, Control Material for Quality Assessment of Quantitative Determination of Hepatitis B Surface Antigen (HBsAg) in Clinical Samples Using Chemiluminescent Immunoassay on CL Series Analyzers, then our information portal MEDCOMMERCE can help you with this. To do this, simply fill out the feedback form by clicking on the link FEEDBACK FORM.

The products posted on our website are approved for use in Russia by the state regulator Roszdravnadzor (Federal Service for Surveillance in Healthcare). The information is for informational purposes only.